Replies to post #11294 on ANI Pharmaceuticals (ANIP)

[LordDarley]

Sad for any of us who bought at $60 (or above).

Still, I think with some good news from the FDA and a deal announcement, we'll be back to 80, but that's not scientific. Just looking at the fact we've been there before.

MNK is a fascinating puzzle, and the CEO is really impressive. This COVID 19 hiatus is going to be tough for them. The litigation summary for all the litigation - opioid suits, etc. - requires extraordinary strategy. I think they could pull it off, but it will require lots of luck.

That's it for tonight.